Results 141 to 150 of about 3,981,458 (213)

Emerging data on thrombopoietin receptor agonists for management of chemotherapy-induced thrombocytopenia. [PDF]

Expert Rev Hematol, 2023
Song AB, Al-Samkari H.
europepmc   +1 more source

P35 | Adverse reaction to rituximab: an unusual case of drug- induced trombocytopenia

Italian Journal of Medicine
Premises: Chemotherapy-induced thrombocytopenia is a common complication. Rituximab, an anti-CD20 monoclonal antibody, induces lysis of B cells only. We describe an acute thrombocytopenia induced by rituximab associated with anaphylaxis and acute kidney
doaj   +1 more source

A single center experience with romiplostim for the management of chemotherapy‐induced thrombocytopenia [PDF]

American Journal of Hematology, 2018
Jennifer Miao, Houry Leblebjian, Bridget Scullion, Aric Parnes   +3 more
openaire   +2 more sources

Chemotherapy-induced thrombocytopenia: from "platelet counting" to ecological repair of the bone marrow. [PDF]

Support Care Cancer
Liu T, Xie R, He Q, Ma J.
europepmc   +1 more source

Efficacy and clinical outcomes of proximal splenic artery embolization in patients with chemotherapy induced thrombocytopenia. [PDF]

Langenbecks Arch Surg
Körfer D, Dijkstra M, Schiro B, Pena C, Landinez G, Narayanan G, Powell A, Gandhi R.   +7 more
europepmc   +1 more source

Thrombopoietin receptor agonists for chemotherapy-induced thrombocytopenia: a new solution for an old problem. [PDF]

Hematology Am Soc Hematol Educ Program, 2022
Al-Samkari H.
europepmc   +1 more source

Eltrombopag for Chemotherapy-Induced Thrombocytopenia: A Multicenter Retrospective Real-World Study. [PDF]

Hematol Rep
Baysal M, Köseoğlu FD, Sadri S, Ataş Ü, Demirci U, Çiftçiler R, Akpınar S, Ümit EG.   +7 more
europepmc   +1 more source

Efficacy of eltrombopag in combination with recombinant human thrombopoietin (rhTPO) for lymphoma patients with chemotherapy-induced thrombocytopenia. [PDF]

Front Pharmacol
Zhu Q, Zeng W, Zhou L, Yang S, Qiu S, Li M, Liu Y, Chen C, Gao Y, Guan Z, Pan X.   +10 more
europepmc   +1 more source

Healthy Participant Versus Patient Selection for Clinical Pharmacology Studies in Small‐Molecule Oncology Drug Development

Clinical and Translational Science, Volume 19, Issue 11, November 2026.
Paridhi Gupta, Zheyi Hu, Li Zhu, Lora Hamuro   +3 more
wiley   +1 more source

Romiplostim for refractory chemotherapy-induced thrombocytopenia in a long-term survivor of limited-stage small cell lung cancer: a case report. [PDF]

Front Oncol
Wang M, Tian P, Huang T, Sun K, Liu J, Wang P.   +5 more
europepmc   +1 more source